Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11858927
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted -
US 11858930
Fused bicyclic RAF inhibitors and methods for use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11858957
Ectonucleotidase inhibitors and methods of use thereof
granted -
US 11858937
Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
granted -
US 11858925
GAS41 inhibitors and methods of use thereof
granted -
US 11851443
Neprilysin inhibitors
granted -
US 11851449
Heterocyclic amide compounds having an RORvt inhibitory action
granted -
US 11845747
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
granted -
US 11844799
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
granted -
US 11844801
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 11845989
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11845808
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11844779
PKC-Delta-I inhibitor formulations and uses thereof
granted -
US 11840540
Dimers of covalent NFKB inhibitors
granted -
US 11840536
Heterocyclic inhibitors of PTPN11
granted -
US 11840525
Use of AURKB small-molecule inhibitors for treatment of non-small cell lung cancer
granted -
US 11834515
Macrocyclic compounds as proteasome inhibitors
granted -
US 11834436
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 11833160
Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseases
granted -
US 11833210
ASH1L inhibitors and methods of treatment therewith
granted -
US 2023381101
AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
granted -
US 11826408
CD200 inhibitors and methods of use thereof
granted -
US 11827637
Azaindole derivatives and their use as ERK kinase inhibitors
granted